Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization ...0

"Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®" "While maintaining the current process for emergency use authorization for mild-to-moderate COVID-19 patients, Hyundai Bioscience will expedite Phase 3 clinical...

Read More Details
Finally We wish PressBee provided you with enough information of ( Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization )

Also on site :

• Josh Charles in 'The Handmaid's Tale' Makes Bold Impression as Commander Wharton
• W. Bank leaders sound alarm over Israel control of Hebron mosque
• Germany halts UN refugee resettlement programme